𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Blood group isoantigen deletion in carcinoma in situ of the urinary bladder

✍ Scribed by Ronald S. Weinstein; Joseph Alroy; George M. Farrow; Alexander W. Miller III; Israel Davidsohn


Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
816 KB
Volume
43
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Survival of patients with carcinoma in s
✍ Liang Cheng; John C. Cheville; Roxann M. Neumann; Bradley C. Leibovich; Kathleen πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 175 KB πŸ‘ 2 views

## BACKGROUND. To the authors' knowledge, the long term follow-up of patients with carcinoma in situ of the urinary bladder is limited. ## METHODS. The authors studied 138 patients diagnosed with urothelial carcinoma in situ of the bladder at the Mayo Clinic between 1972-1979. All the histologi

Pathology of carcinoma in situ of the ur
✍ George M. Farrow πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 477 KB

In the United States, nearly all cases of bladder cancer are of the transitional cell type, and epidemiological evidence indicates that among these, approximately 80% present initially as more or less well-differentiated, superficial papillary neoplasms with a tendency for multifocal or diffuse invo

Carcinoma in situ of the bladder
✍ A. J. Yates-Bell πŸ“‚ Article πŸ“… 1971 πŸ› John Wiley and Sons 🌐 English βš– 764 KB
Consistent genomic alterations in carcin
✍ Karsten Zieger; Niels Marcussen; Michael Borre; Torben F. Ørntoft; Lars DyrskjΓΈt πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 256 KB

## Abstract Bladder cancer develops through different pathways, provisionally entitled β€œpapillary” and β€œinvasive.” Carcinoma __in situ__ (CIS) is thought to be the precursor of invasive bladder cancer. However, little is known about chromosomal alterations of these clinically important lesions, and